Contents of this filing
The company has resolved to relocate its head office and submit to the general meeting of shareholders amendments to the Articles of Incorporation to change the head office location from Chuo-ku, Tokyo, to Osaka City, Osaka Prefecture.
この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。
| Item | Details |
|---|---|
| Changes this time | The company has resolved to relocate its head office and submit to the general meeting of shareholders amendments to the Articles of Incorporation to change the head office location from Chuo-ku, Tokyo, to Osaka City, Osaka Prefecture. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further strengthen activities and collaboration in the Kansai region, where regenerative medicine research and industry hubs are concentrated and which has strong ties to the company’s business, based on achievements including exhibiting products at Expo 2025 Osaka, Kansai, Japan and obtaining conditional, time-limited manufacturing and marketing approval for “ReHeartⓇ.”